verapamil has been researched along with Bone Diseases, Metabolic in 1 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adult female and male Sprague-Dawley rats received verapamil in their drinking water at a dosage of 0." | 1.28 | Verapamil induces increased bone volume and osteopenia in female rats but has the opposite effect in male rats. ( Samnegård, E; Sjödén, G, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samnegård, E | 1 |
| Sjödén, G | 1 |
1 other study available for verapamil and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Verapamil induces increased bone volume and osteopenia in female rats but has the opposite effect in male rats.
Topics: Administration, Oral; Animals; Bone and Bones; Bone Diseases, Metabolic; Calcium; Dose-Response Rela | 1992 |